Bangor Savings Bank Catalyst Pharmaceuticals, Inc. Transaction History
Bangor Savings Bank
- $1.06 Billion
- Q4 2024
A detailed history of Bangor Savings Bank transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Bangor Savings Bank holds 100 shares of CPRX stock, worth $2,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,067
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$386 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$120 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$64.8 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$62.3 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.13B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...